

RESOURCES
Staying in
the know
We are committed to developing safe and effective therapies to help transform realities for those living with rare liver disease. But that also means helping you stay current and up to date on what is going on today. Learn more about resources that are available to provide support to you and your family.


Access
to genetic
testing
Mirum is working alongside Travere Therapeutics to provide support to
ensure qualified patients have access to the Emory Genetics Lab genetic
cholestasis panel at no charge. This panel may assist in diagnosing a
cholestatic liver disease.


ALGS Vitamins and Supplements Fund
Patients with Alagille syndrome (ALGS) often experience a reduced flow of bile to the small intestine which can cause problems digesting fats and absorbing fat-soluble vitamins such as vitamins A, D, E, and K. These deficiencies may cause malnutrition and contribute to complications related to growth. As such, vitamins often become an essential component to care for children with ALGS.
The HealthWell Foundation, a US-based organization, has launched a new fund to provide financial assistance to patients living in the U.S. with ALGS. Through the fund, eligible patients within the U.S. and U.S. territories who have annual household incomes up to 500 percent of the federal poverty level can qualify for up to $1,500 in financial assistance to obtain vitamins and supplements for the management of their condition.


Support for living with a rare disease
Find support for people and families living with rare disease:
Information about Alagille syndrome (ALGS)
Information about progressive familial
intrahepatic cholestasis (PFIC)
Information about biliary atresia (BA)
Expanded
access
for
LIVMARLI® (maralixibat)
oral solution
LIVMARLI (maralixibat) for eligible patients with ALGS and PFIC.
Mirum Access Plus (MAP)
Designed to help patients and families start and stay onLIVMARLI (maralixibat), this program connects patients and
families with MAP experts who can help educate on the
journey, from treatment access to financial support.

